PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
20-Sep-2023 Adtralza®▼(tralokinumab) is granted marketing authorisation from MHRA for a new pre-filled pen LEO Pharma
20-Sep-2023 Global Fibromyalgia Treatment Market Is Anticipated to grow at a steady CAGR of 3.3% By 2032 KD Market Insights
20-Sep-2023 uMed Partners with The Michael J. Fox Foundation to Support Wide-scale Study Exploring Link Between Smell Loss and Parkinson’s uMed
20-Sep-2023 Abbott and WeightWatchers Connected App Experience is Now Available for People Living With Diabetes Abbott
20-Sep-2023 Transimmune Secures $5m Funding to Enhance mRNA Vaccination with Novel Dendritic Cell Therapy Transimmune
19-Sep-2023 Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth Mural Health
19-Sep-2023 Investment in diabetes-focused AI companies exceeds $361 million in 2023 Aging Analytics Agency
19-Sep-2023 Evaluate Expands its Competitive Intelligence Practice Evaluate
19-Sep-2023 ALSA Ventures launches novel Gene Therapy portfolio company Axovia Therapeutics to treat Ciliopathies ALSA Ventures
19-Sep-2023 UPS Strengthens Healthcare Service in Southern France with Acquisition of Transports Chabas Santé UPS
19-Sep-2023 Integrated DNA Technologies and Aldevron® Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers Integrated DNA Technologies / Aldevron
19-Sep-2023 Biofourmis Accelerates and Simplifies Drug Development with Expanded Digital Clinical Trials Solution Biofourmis
19-Sep-2023 ABB and Porsche Consulting driving the future of analyzer manufacturing ABB
19-Sep-2023 3P Biopharmaceuticals continues its successful collaboration with Toleranzia AB to fight Myasthenia Gravis 3P Biopharmaceuticals
19-Sep-2023 Oxford BioTherapeutics to Participate in Panel Discussion at Boehringer Ingelheim’s Upcoming Transforming Science Day: Europe Oxford BioTherapeutics
19-Sep-2023 Over 50’s back auto-enrolment in clinical trials tackling long-term health conditions Lindus Health
19-Sep-2023 Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia Otsuka Pharmaceutical Europe Ltd
19-Sep-2023 Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research Olink Holding AB
19-Sep-2023 NecstGen and ProteoNic Report Development of Improved Viral Vectors through the Application of Premium 2G UNic™ Technology NecstGen / ProteoNic
19-Sep-2023 European Commission authorises ViiV Healthcare’s Apretude (cabotegravir long-acting and tablets) for HIV prevention ViiV Healthcare